Crossmark

Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein Destabilization

Crossref DOI link: https://doi.org/10.1007/s12035-018-1449-2

Published Online: 2018-12-27

Published Print: 2019-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

De Wit, T.

Baekelandt, V.

Lobbestael, E.
Funding

Funding for this research was provided by:

Michael J. Fox Foundation for Parkinson's Research (11472)

Agentschap Innoveren en Ondernemen (IWT.141396)

Fonds Wetenschappelijk Onderzoek (SBOS006617N, G0E1917N)
License Information

Text and Data Mining valid from 2018-12-27
More Information

Article History

Received: 30 May 2018

Accepted: 6 December 2018

First Online: 27 December 2018

Compliance with Ethical Standards

: All animal experiments were performed in accordance with the European Communities Council Directive of November 24, 1986 (86/609/EEC) and approved by the Bioethical Committee of the KU Leuven (Belgium).

: The authors declare that they have no conflict of interest.